Inflammatory mediator antagonists
OwnerPaul F. Life, Edward S. Rees +1inventors
InventorsPaul F. Life, Edward S. Rees, Andrew D. Rhodes
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of an antagonist of OSM such as an antibody or small molecule in the manufacture of a medicament for the treatment or prophylaxis of an inflammatory arthropathy or inflammatory disorder, and the use of OSM in screening for such antagonists.
Claims19
A method of treating an inflammatory arthropathy or an inflammatory disorder comprising administering to a patient in need thereof an effective amount of an antagonist to oncostatin M (OSM) or an OSM receptor.
A pharmaceutical composition comprising a unit dose of at least 1 mg, of an antagonist to oncostatin M (OSM), and a pharmaceutically acceptable carrier.
An assay for the identification of an antagonist of oncostatin M (OSM) comprising combining OSM or an OSM binding moiety and an OSM receptor or receptor conjugate with a test agent and monitoring for blocking of the interaction between OSM or the OSM binding moiety and the OSM receptor or receptor conjugate.
An aptamer selected from the group consisting of aptamers shown in FIG. 16.
Dependencies are inferred from the claim text.